Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A06671 | 32785220 | PLoS One | Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet. | 2020 | Details |
A06672 | 32785111 | J Clin Med | Metabolic Footprint, towards Understanding Type 2 Diabetes beyond Glycemia. | 2020 | Details |
A06673 | 32785100 | Diagnostics (Basel) | Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A06674 | 32785059 | Nutrients | Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral. | 2020 | Details |
A06675 | 32785012 | Int J Mol Sci | Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
A06676 | 32784205 | BMJ Open Gastroenterol | Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2020 | Details |
A06677 | 32783933 | Cell Rep | Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis. | 2020 | Details |
A06678 | 32783310 | Int J Exp Pathol | A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. | 2020 | Details |
A06679 | 32782954 | JGH Open | Effect of telmisartan and vitamin E on liver histopathology with non-alcoholic steatohepatitis: A randomized, open-label, noninferiority trial. | 2020 | Details |
A06680 | 32782883 | Cureus | An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A06681 | 32782033 | Microsc Microanal | Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine-Choline-Deficient Diet-Induced NAFLD. | 2020 | Details |
A06682 | 32781739 | Nutrients | The Root of Polygonum multiflorum Thunb. Alleviates Non-Alcoholic Steatosis and Insulin Resistance in High Fat Diet-Fed Mice. | 2020 | Details |
A06683 | 32781293 | Comp Biochem Physiol C Toxicol Pharmacol | Higher intestinal and circulatory lactate associated NOX2 activation leads to an ectopic fibrotic pathology following microcystin co-exposure in murine fatty liver disease. | 2020 | Details |
A06684 | 32781086 | Gastroenterology | Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
A06685 | 32780887 | FASEB J | Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet-induced ER stress. | 2020 | Details |
A06687 | 32780624 | Metab Syndr Relat Disord | Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes. | 2020 | Details |
A06688 | 32780531 | Mol Nutr Food Res | Lactobacillus rhamnosus GG and Oat Beta-Glucan Regulated Fatty Acid Profiles along the Gut-Liver-Brain Axis of Mice Fed with High Fat Diet and Demonstrated Antioxidant and Anti-Inflammatory Potentials. | 2020 | Details |
A06689 | 32780094 | Inflamm Bowel Dis | Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
A06690 | 32779505 | J Am Heart Assoc | Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers. | 2020 | Details |
A06691 | 32779442 | Cell J | Nicotinamide Phosphoribosyltransferase Knockdown Leads to Lipid Accumulation in HepG2 Cells through The SIRT1-AMPK Pathway. | 2020 | Details |
A06692 | 32779242 | Hepatology | 17-Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury. | 2021 | Details |
A06693 | 32777485 | Phytomedicine | Cajanolactone A, a stilbenoid from cajanus cajan, prevents ovariectomy-induced obesity and liver steatosis in mice fed a regular diet. | 2020 | Details |
A06694 | 32777482 | Biochim Biophys Acta Mol Cell Biol Lipids | Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions. | 2020 | Details |
A06695 | 32777481 | Biochim Biophys Acta Mol Cell Biol Lipids | Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. | 2020 | Details |
A06696 | 32777136 | FASEB J | Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway. | 2020 | Details |
A06697 | 32776921 | PLoS Genet | Disruption of the ERLIN-TM6SF2-APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease. | 2020 | Details |
A06698 | 32776116 | Endocrinology | NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment. | 2020 | Details |
A06699 | 32775976 | JHEP Rep | Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. | 2020 | Details |
A06700 | 32775974 | JHEP Rep | Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. | 2020 | Details |
A06701 | 32775971 | EClinicalMedicine | Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database. | 2020 | Details |
A06702 | 32775350 | Visc Med | The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome. | 2020 | Details |
A06703 | 32775322 | Front Bioeng Biotechnol | Computational Modeling of Fructose Metabolism and Development in NAFLD. | 2020 | Details |
A06704 | 32775098 | Cureus | Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials. | 2020 | Details |
A06705 | 32774848 | Ann Med Surg (Lond) | Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East. | 2020 | Details |
A06706 | 32774765 | World J Gastrointest Surg | Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. | 2020 | Details |
A06707 | 32774711 | Am J Transl Res | Changes and roles of intestinal fungal microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. | 2020 | Details |
A06708 | 32774420 | Evid Based Complement Alternat Med | Anti-inflammatory Mechanism of Ruzu Bitters on Diet-Induced Nonalcoholic Fatty Liver Disease in Male Wistar Rats. | 2020 | Details |
A06709 | 32774148 | Mediators Inflamm | Understanding the Role of Exercise in Nonalcoholic Fatty Liver Disease: ERS-Linked Molecular Pathways. | 2020 | Details |
A06710 | 32773176 | HPB (Oxford) | Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. | 2020 | Details |
A06711 | 32773026 | Biol Aujourdhui | [ER stress and NAFLD]. | 2020 | Details |
A06712 | 32773025 | Biol Aujourdhui | [Cell death mechanisms in non-alcoholic steatohepatitis]. | 2020 | Details |
A06713 | 32772909 | Comb Chem High Throughput Screen | Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration. | 2021 | Details |
A06714 | 32772844 | Trop Doct | Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India. | 2020 | Details |
A06715 | 32772323 | J Endocrinol Invest | Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. | 2020 | Details |
A06716 | 32771802 | Atherosclerosis | Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease. | 2020 | Details |
A06717 | 32771373 | Peptides | Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway. | 2020 | Details |
A06719 | 32770818 | Liver Int | Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model. | 2020 | Details |
A06720 | 32770081 | Exp Mol Med | Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. | 2020 | Details |
A06721 | 32769900 | Medicine (Baltimore) | Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis. | 2020 | Details |
A06722 | 32769877 | Medicine (Baltimore) | Protective effect of probiotics in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A06724 | 32768590 | Clin Gastroenterol Hepatol | Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies. | 2020 | Details |
A06725 | 32768394 | Ann Endocrinol (Paris) | Impact of aerobic training with and without whole-body vibration training on metabolic features and quality of life in non-alcoholic fatty liver disease patients. | 2020 | Details |
A06726 | 32768187 | Biochem Biophys Res Commun | Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH. | 2020 | Details |
A06728 | 32767607 | J Paediatr Child Health | High prevalence of elevated serum liver enzymes in Chinese children suggests metabolic syndrome as a common risk factor. | 2020 | Details |
A06729 | 32767404 | Cell Biochem Funct | Apoptosis-inducing factor deficient mice fail to develop hepatic steatosis under high fat high fructose diet or bile duct ligation. | 2020 | Details |
A06730 | 32766475 | Hepatol Commun | Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway. | 2020 | Details |
A06731 | 32766474 | Hepatol Commun | Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. | 2020 | Details |
A06732 | 32766473 | Hepatol Commun | Genome-Wide Association Study of Lean Nonalcoholic Fatty Liver Disease Suggests Human Leukocyte Antigen as a Novel Candidate Locus. | 2020 | Details |
A06733 | 32766472 | Hepatol Commun | Genome-Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study. | 2020 | Details |
A06734 | 32765812 | Nutr Res Pract | Folic acid supplementation prevents high fructose-induced non-alcoholic fatty liver disease by activating the AMPK and LKB1 signaling pathways. | 2020 | Details |
A06735 | 32765720 | Exp Ther Med | Non-alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review). | 2020 | Details |
A06736 | 32765626 | Evid Based Complement Alternat Med | Improvement in Menopause-Associated Hepatic Lipid Metabolic Disorders by Herbal Formula HPC03 on Ovariectomized Rats. | 2020 | Details |
A06737 | 32765601 | Gastroenterol Res Pract | Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare. | 2020 | Details |
A06738 | 32765518 | Front Immunol | Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis. | 2020 | Details |
A06739 | 32765301 | Front Physiol | Lipophagy Impairment Is Associated With Disease Progression in NAFLD. | 2020 | Details |
A06740 | 32764281 | Nutrients | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. | 2020 | Details |
A06741 | 32763355 | Toxicol Appl Pharmacol | Hesperetin protects against palmitate-induced cellular toxicity via induction of GRP78 in hepatocytes. | 2020 | Details |
A06742 | 32763266 | J Hepatol | Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. | 2020 | Details |
A06744 | 32763196 | Lancet Gastroenterol Hepatol | A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. | 2020 | Details |
A06745 | 32762830 | J Pharm Pharm Sci | Cannabis and the Gastrointestinal Tract. | 2020 | Details |
A06746 | 32762728 | BMC Pharmacol Toxicol | Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease. | 2020 | Details |
A06747 | 32762395 | J Int Med Res | Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study. | 2020 | Details |
A06748 | 32760938 | Food Funct | Dietary citrus peel essential oil ameliorates hypercholesterolemia and hepatic steatosis by modulating lipid and cholesterol homeostasis. | 2020 | Details |
A06749 | 32760204 | Int J Biol Sci | Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe? | 2020 | Details |
A06750 | 32760200 | Int J Biol Sci | Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism. | 2020 | Details |
A06751 | 32759940 | Nutr Diabetes | Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice. | 2020 | Details |
A06752 | 32759852 | Int J Mol Sci | Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
A06753 | 32759548 | Biol Pharm Bull | Amelioration of the Lipogenesis, Oxidative Stress and Apoptosis of Hepatocytes by a Novel Proteoglycan from Ganoderma lucidum. | 2020 | Details |
A06755 | 32759166 | BMJ Open Diabetes Res Care | Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation. | 2020 | Details |
A06756 | 32758573 | Eur J Pharmacol | Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways. | 2020 | Details |
A06757 | 32758151 | BMC Gastroenterol | Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems. | 2020 | Details |
A06759 | 32757283 | Fundam Clin Pharmacol | Protective effect of fenofibrate against high-fat-high-fructose diet induced non-obese NAFLD in rats. | 2020 | Details |
A06760 | 32757159 | Dig Dis Sci | External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. | 2020 | Details |
A06761 | 32757050 | Eur Radiol | Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
A06762 | 32756704 | Food Funct | Recombinant human lactoferrin attenuates the progression of hepatosteatosis and hepatocellular death by regulating iron and lipid homeostasis in ob/ob mice. | 2020 | Details |
A06763 | 32756323 | J Clin Med | Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. | 2020 | Details |
A06764 | 32756082 | Medicine (Baltimore) | Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2020 | Details |
A06765 | 32755726 | Biochim Biophys Acta Mol Cell Biol Lipids | miR-3666 inhibits development of hepatic steatosis by negatively regulating PPARγ. | 2020 | Details |
A06766 | 32755310 | Am J Physiol Gastrointest Liver Physiol | The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
A06767 | 32754976 | Mol Nutr Food Res | Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism. | 2020 | Details |
A06768 | 32754942 | Magn Reson Med | Simultaneous proton density fat-fraction and R 2 ∗ imaging with water-specific T1 mapping (PROFIT1 ): application in liver. | 2020 | Details |
A06769 | 32754608 | Front Med (Lausanne) | How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19? | 2020 | Details |
A06770 | 32753923 | Diabetes Metab Syndr Obes | Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial. | 2020 | Details |
A06771 | 32752595 | J Prev Med Public Health | Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women. | 2020 | Details |
A06772 | 32752277 | Int J Mol Sci | Iron Metabolism in Obesity and Metabolic Syndrome. | 2020 | Details |
A06773 | 32751983 | Biomolecules | Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development. | 2020 | Details |
A06774 | 32751906 | Nutrients | Efficacy of Dietary Supplements to Reduce Liver Fat. | 2020 | Details |
A06775 | 32751794 | Int J Mol Sci | Cold Press Pomegranate Seed Oil Attenuates Dietary-Obesity Induced Hepatic Steatosis and Fibrosis through Antioxidant and Mitochondrial Pathways in Obese Mice. | 2020 | Details |
A06776 | 32751772 | Nutrients | Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity. | 2020 | Details |
A06777 | 32751658 | Cells | The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. | 2020 | Details |